Dr. Benjamin Bikman
Associate Professor of Cell Biology and Physiology, BYU
Insulin resistance • cardiometabolic disease • bioenergetics
About the expert
Focus: Insulin resistance and metabolic disease
Benjamin Bikman is an associate professor at Brigham Young University, where he studies the relationship between insulin resistance and cardiometabolic disease. He holds a PhD in Bioenergetics from East Carolina University and completed postdoctoral training in metabolic disorders at Duke-NUS Medical School. He is co-founder of HLTH Code and Insulin IQ, and author of Why We Get Sick (2020).
Why this matters
BYU metabolic researcher who frames insulin resistance as the connector across multiple cardiometabolic conditions. The insulin-resistance-as-cardiovascular-driver framing is broadly mainstream; the carbohydrate-insulin model as the primary driver of obesity is still actively contested in the energy-balance literature. Bikman has commercial exposure (co-founder of HLTH Code and Insulin IQ, author of Why We Get Sick), which is relevant context when he is the source of a specific protocol or substance recommendation, although it does not itself invalidate the underlying physiology he discusses. Strongest on mechanism; worth pairing with conventional clinical-outcome evidence when the conversation moves from mechanism to recommended daily protocol. In his glucagon lecture he treats low insulin, reached mainly through low-carb eating, as the bigger lever for fat burning than glucagon itself, which is his interpretation rather than established weight-loss guidance.